Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Immunocore Hldgs plc (IMCR)

144 + Investors. Track Smart Money conviction in IMCR. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -5
Streak
1Q ▼
Buyers last Q
52%

Smart Money Signals — IMCR

Based on 145 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their IMCR positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
🏔️

At the ownership peak (97% of max)

97% of all-time peak
145 hedge funds hold IMCR right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +24% more funds vs a year ago

fund count last 6Q
+28 new funds entered over the past year (+24% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks. The peak was reached in just 4 quarters from the low — a sharp move.
🟡

Slight buying edge — 52% buying

80 buying73 selling
Last quarter: 80 funds bought or added vs 73 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-8 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 32 → 17 → 32 → 24. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

54% of holders stayed for 2+ years

■ 54% conviction (2yr+) ■ 26% medium ■ 20% new
79 out of 145 hedge funds have held IMCR for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +17%, value -3%

Value
-2%
Shares
+16%
Last quarter: funds added +17% more shares while total portfolio value only changed -3%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📈

Growing discovery — still being found

15 → 32 → 17 → 32 → 24 new funds/Q
New funds entering each quarter: 32 → 17 → 32 → 24. A growing number of institutions are discovering IMCR each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Veteran-anchored — 63% veterans vs 23% newcomers

■ 63% veterans ■ 14% 1-2yr ■ 23% new
Entry-cohort mix of 154 holders: 97 (63%) are 2+ year veterans, 22 entered 1–2 years ago, and 35 (23%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
✅

Strong quality — 37% AUM from major funds

37% from top-100 AUM funds
32 of 143 holders rank in the top 100 by AUM, accounting for 37% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
3.7
out of 10
Low Exit Risk
Exit risk score 3.7/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — IMCR

In 2026 Q1, 80 hedge funds were net buyers of IMCR (24 opened a new position, 56 added to an existing one), while 73 reduced or exited (44 trimmed, 29 sold completely) — a 52% buyer ratio, indicating a slight buying edge. 37% of total institutional value in IMCR is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: -5 funds (more exits than new entries). Total institutional holders: 145.

Hedge Fund Ownership: IMCR

How many hedge funds hold IMCR — quarterly history vs. share price
Quarterly hedge fund ownership of IMCR vs. share price

Market Analysis: IMCR

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: IMCR

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Immunocore Hldgs plc (IMCR) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much IMCR has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 80d ago
IMCR
nan%
XLV
+2.1%

IMCR outperformed XLV by nan% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 35d ago
IMCR
nan%
XLV
+3.2%

Since the filing became public, IMCR outperformed XLV by nan% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

11 top-rated funds 4 high-conviction
Consensus
4.7
/ 10
breadth
×
Elite
3.3
/ 10
conviction
Hedge Fund Positioning: IMCR
144 + Investors

Track Smart Money conviction in IMCR. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 144 150 -4.0%
13F Shares 55M 47M 16.87%
Total Value $1.54B $1.58B -2.64%
New Positions 23 32 -9
Increased Positions 53 47 +6
Closed Positions 29 15 +14
Reduced Positions 42 40 +2
Total Calls 5 4 25.0%
Total Puts 6 5 20.0%
PUT/CALL Ratio 1.2 1.25 Neutral

Statistics: IMCR

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

144 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in IMCR. Verified SEC 13F-HR filings.

QUARTER:
Top 25 IMCR holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Trails Edge Capital Partners, LP 4.71% 682,597 $20.6M
2 Tang Capital Management LLC 4.06% 2,649,368 $79.9M
3 Eschler Asset Management LLP 2.40% 80,000 $2.4M
4 Vestal Point Capital, LP 2.33% 2,766,868 $83.4M
5 Logos Global Management LP 2.26% 1,500,000 $45.2M
6 Bellevue Group AG 2.01% 2,796,803 $84.3M
7 Kynam Capital Management, LP 1.65% 884,937 $26.7M
8 Rtw Investments, LP 1.46% 4,869,798 $146.8M
9 Bvf Inc/Il 1.24% 1,294,463 $39.0M
10 Diadema Partners LP 0.99% 193,189 $5.8M
11 Deep Track Capital, LP 0.95% 1,931,884 $58.2M
12 Armistice Capital, LLC 0.64% 1,188,000 $35.8M
13 Persistent Asset Partners Ltd 0.55% 48,962 $1.5M
14 Catalio Capital Management, LP 0.53% 84,352 $2.5M
15 Elmind Capital, LP 0.50% 58,248 $1.8M
16 HighVista Strategies LLC 0.49% 58,697 $1.8M
17 Hussman Strategic Advisors, INC. 0.41% 63,000 $1.9M
18 Frazier Life Sciences Management, L.P. 0.38% 484,782 $14.6M
19 Stempoint Capital LP 0.37% 63,543 $1.9M
20 PSP Research LLC 0.32% 15,141 $457K
21 Rhenman & Partners Asset Management AB 0.32% 85,724 $2.6M
22 Eagle Health Investments LP 0.24% 46,300 $1.4M
23 Caption Management, LLC 0.22% 1,242,500 $37.5M
24 Virtus Investment Advisers, LLC 0.19% 22,940 $692K
25 Integral Health Asset Management, LLC 0.14% 100,000 $3.0M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Immunocore Hldgs plc (IMCR)

What does the Smart Money Trend signal show for IMCR?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their IMCR positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for IMCR?

Slight buying edge — 52% buying: Last quarter: 80 funds bought or added vs 73 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for IMCR holders?

Strong quality — 37% AUM from major funds: 32 of 143 holders rank in the top 100 by AUM, accounting for 37% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held IMCR?

54% of holders stayed for 2+ years: 79 out of 145 hedge funds have held IMCR for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Immunocore Hldgs plc (IMCR) following the 2026 Q1 hedge fund 13F filings?

As of today, IMCR has moved nan% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of nan%. Since the quarter end (March 31, 2026), IMCR has gained nan% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →